Year Wise Statistics
Total Downloads
328,413
Fulltext
248,235
PDF
80,178
328,413
Fulltext
248,235
80,178
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Review ArticleMini review: Molecular pathology of personalized medicine in cancer susceptibility syndromesFull text |  PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023 |
16,482 | 1,513 | 17,995 |
Original ArticleOutcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from IndiaFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023 |
15,894 | 1,481 | 17,375 |
EditorialChallenging conventional wisdom in molecular oncology: New perspectivesFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023 |
15,815 | 1,501 | 17,316 |
Case ReportLong-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in IndiaFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023 |
15,935 | 1,372 | 17,307 |
Review ArticleMolecular oncology and the role of artificial intelligence in advancing cancer treatmentFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023 |
15,404 | 1,034 | 16,438 |
EditorialCrucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancerFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024 |
11,155 | 1,492 | 12,647 |
Review ArticleHigh-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspectiveFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024 |
11,486 | 1,075 | 12,561 |
Review ArticleUnderstanding immunotherapy and CAR-T-cells: A narrative reviewFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023 |
11,363 | 1,155 | 12,518 |
Review ArticleUse of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective articleFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024 |
11,244 | 1,049 | 12,293 |
Original ArticleSpectrum of lymphomas in IndiaFull text | PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023 |
11,151 | 542 | 11,693 |
Review ArticleSignaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targetsFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022 |
5,716 | 1,069 | 6,785 |
Case ReportSquamous cell carcinoma of lung presenting as “Sunray sign” in chest radiographFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023 |
5,513 | 1,230 | 6,743 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020 |
5,724 | 739 | 6,463 |
Case ReportL1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case reportFull text | PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023 |
5,255 | 817 | 6,072 |
Review ArticlePotential therapeutic molecular targets for better outcomes for patients with lung cancerFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022 |
5,602 | 411 | 6,013 |
Review ArticleCombination of PARPi and anti-PD-L1 therapies in ovarian cancerFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022 |
5,402 | 586 | 5,988 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022 |
994 | 1,723 | 2,717 |
Original ArticlePrevalence of germline mutations in women with breast and/or ovarian cancer in a tertiary care center in Pune, IndiaFull text | PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_5_2023 |
1,983 | 533 | 2,516 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019 |
1,657 | 668 | 2,325 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
1,765 | 514 | 2,279 |
Review ArticlePost-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspectiveFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021 |
919 | 1,055 | 1,974 |
Review ArticleImpact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic reviewFull text | PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019 |
866 | 1,066 | 1,932 |
Case ReportClinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022 |
1,148 | 710 | 1,858 |
Brief CommentaryERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginningFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021 |
716 | 1,125 | 1,841 |
Review ArticleImmune dynamics of SARS-CoV-2 virus evolutionFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021 |
744 | 1,080 | 1,824 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022 |
1,267 | 551 | 1,818 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020 |
1,081 | 723 | 1,804 |
Review ArticleMolecular genetics changes in gallbladder carcinomaFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019 |
1,165 | 571 | 1,736 |
Original ArticleAdvanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian association for regional cooperation regionFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2021 |
1,007 | 715 | 1,722 |
Review ArticleResistance to poly ADP-ribose polymerase inhibitors and its clinical implicationsFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022 |
857 | 831 | 1,688 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020 |
1,029 | 642 | 1,671 |
Review ArticleAlpha-fetoprotein: A molecular bootstrap for hepatocellular carcinomaFull text | PDF Year: 2020, Volume: 5, Issue: 3, September-December DOI: 10.25259/IJMIO_5_2020 |
1,272 | 348 | 1,620 |
Review ArticleImmuno-oncology of differentiated thyroid cancerFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020 |
959 | 612 | 1,571 |
New Drug UpdateAmlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitorFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021 |
630 | 933 | 1,563 |
EditorialMolecular insights into tumor microenvironment and targeted therapiesFull text | PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_28_2021 |
590 | 969 | 1,559 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019 |
810 | 730 | 1,540 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December |
954 | 551 | 1,505 |
Review ArticleMolecular targets in urinary bladder cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_4_2022 |
1,042 | 456 | 1,498 |
Review ArticleClinical trials landscape in Sri LankaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_29_2020 |
1,060 | 368 | 1,428 |
Review ArticleA compendium of population wide DNA methylation profile for oral cancer in IndiaFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021 |
752 | 673 | 1,425 |
Original ArticleIncorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?Full text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022 |
725 | 695 | 1,420 |
Review ArticleHER2 ‘neu’ promise for mCRCFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2022 |
558 | 839 | 1,397 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
940 | 436 | 1,376 |
Review ArticleThe evolving role of precision medicine in the management of advanced sarcomas – A mini reviewFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021 |
857 | 500 | 1,357 |
Original ArticleAssessment of mismatch repair protein expression by immunohistochemistry in endometrial carcinomas with clinicopathological correlation: A study from Indian Tertiary Cancer Care CentreFull text | PDF Year: 2020, Volume: 5, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2020 |
1,094 | 259 | 1,353 |
Review ArticleClinical application of molecular genetics in acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_22_2022 |
992 | 360 | 1,352 |
Case ReportCHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathwayFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_25_2022 |
1,026 | 312 | 1,338 |
EditorialImmune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!Full text | PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_23_2019 |
467 | 870 | 1,337 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022 |
724 | 587 | 1,311 |
Case ReportMetastatic endometrial carcinoma responsive to pembrolizumabFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020 |
705 | 599 | 1,304 |
